Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain
Elena Bandieri(Roche (Switzerland)), Carla Ripamonti(University of Brescia), Fabrizio Artioli(Roche (Switzerland)), Daniela Sichetti(Roche (Switzerland)), PierFranco Conte(University of Padua), Stefano Cascinu(Vita-Salute San Raffaele University), Éduardo Bruera(The University of Texas MD Anderson Cancer Center), Barbara Melotti(Roche (Switzerland)), Luigi Cavanna(University of Pavia), Caterina Fanizza(Roche (Switzerland)), Marilena Romero(Roche (Switzerland)), Daniele Santini(Policlinico Umberto I), Fausto Roila(Roche (Switzerland)), Mario Luppi(University of Modena and Reggio Emilia), Gianni Tognoni(Mario Negri Sud Foundation)
Cited by 181
Related Papers
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
|IRIS UNIMORE (University of Modena and Reggio Emilia)|2005|1.6k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k